Quantcast
Last updated on April 16, 2014 at 6:17 EDT

Latest Personalized medicine Stories

2013-10-11 23:19:29

Protein Engineering Market report categorizes the market for protein engineering by geography, applications, products and technology. http://www.marketsandmarkets.com/Market-Reports/protein-antibody-engineering-market-898.html (PRWEB) October 11, 2013 The report "Protein Engineering Market [Products (Monoclonal Antibody, Insulin Analog, Modified EPO), Technology (Sequential Modification, Glycosylation, PEGylation), and Applications (Therapeutics, Diagnostics, Research)] - Global...

2013-10-10 23:03:16

Reportbuyer.com just published a new market research report: Personalized Medicine Market Analysis. London (PRWEB) October 10, 2013 Advancements in the field of genomics have created ample opportunities for personalized medicines to emerge in the healthcare industry. Personalized medicine represents an interface of therapeutics and diagnostics. It involves the tailoring of treatments as per individuals. The growing research applications and identification of molecular markers towards...

2013-10-09 08:27:22

Key components include an upgraded online physician portal, simplified genomic profile and newly-added biomarkers to support more informed therapeutic selections IRVING, Texas, Oct. 9, 2013 /PRNewswire/ -- Caris Life Sciences®, a leading biosciences company focused on fulfilling the promise of personalized medicine, today launched significant enhancements to its Molecular Intelligence(TM) tumor profiling service. These enhancements include significant updates to MI Portal(TM), the...

2013-10-09 04:21:07

HAMBURG, Germany, October 9, 2013 /PRNewswire/ -- Sysmex Inostics, a subsidiary of Sysmex Corporation, today announced a master collaboration agreement with Bayer HealthCare for the development of companion diagnostics for targeted cancer therapies. The partnership pairs Sysmex Inostics' innovative blood-based companion diagnostic solutions with targeted anti-cancer agents developed by Bayer. "We are pleased to partner with Bayer HealthCare, a global company with an...

2013-10-08 23:03:42

In-demand research report “Cancer/Tumor Profiling Market [Applications (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognosis, Research), Technologies (NGS, QPCR, IHC, FISH/CISH, Microarray), Segments: Genomics, Proteomics, Metabolomics, Epigenetics)] 2013 – 2018” prepared by MarketsandMarkets has been recently published by Market Publishers Ltd. London, UK (PRWEB) October 08, 2013 In 2012, the world cancer/tumor profiling market surpassed a USD 13.25 billion mark. At...

2013-10-04 16:22:47

MORRISVILLE, N.C., Oct. 4, 2013 /PRNewswire/ -- Gentris Corporation (www.gentris.com), a global leader in pharmacogenomics and biorepository solutions, announced today that Gentris founder, Michael Murphy, and leading cancer pharmacogenomics expert, Dr. Howard McLeod, have joined the Board of Directors. (Logo: http://photos.prnewswire.com/prnh/20130916/CL80771LOGO) "I am excited to welcome Michael Murphy and Dr. Howard McLeod to the Board of Directors," said Tim Gupton, Gentris...

2013-10-04 04:20:26

LAUSANNE, Switzerland, October 4, 2013 /PRNewswire/ -- Debiopharm Group(TM) (Debiopharm), the Swiss-based global biopharmaceutical company that focuses on the development of prescription drugs that target unmet medical needs including oncology and companion diagnostics, will be presenting the 'JCA-Mauvernay Award' on October 5, to Doctors Issay Kitabayashi from Tokyo National Cancer Center Research Institute for his basic research on 'Molecular study of acute myeloid leukemia...

2013-10-02 23:22:13

Reportbuyer.com just published a new market research report: Genetic Testing Market Outlook to 2017. London (PRWEB) October 02, 2013 A recent report, “Genetic Testing Market Outlook to 2017”, provides an in-depth analysis of the current and future genetic testing market. A comprehensive introduction of gene-based tests, their working principles and types are covered in around a 140-page report. On account of our analysis of the past and present market trends; drivers; and existing...

2013-10-02 13:44:20

Study with Geisinger Health System tests nearly 2,300 extremely obese diabetes patients A groundbreaking study of nearly 2,300 extremely obese diabetes patients, led by the Translational Genomics Research Institute (TGen), has identified genes associated with unhealthy liver function. This is believed to be the nation's first large-scale genome-wide association study in overweight patients with diabetes. Results of the study, done in conjunction with the Geisinger Health System, will...

2013-10-01 23:20:50

Molecular Diagnostics Market report categorizes the global market into application, technology and product type. http://www.marketsandmarkets.com/Market-Reports/molecular-diagnostic-market-833.html. (PRWEB) October 01, 2013 The new market research report “Molecular Diagnostics Market - Technologies (PCR, DNA Sequencing, Microarray, Spectroscopy), Applications (Virology/Infectious Diseases, Cancer/Oncology, Genetic Testing) - Global Opportunities, Competitor Analysis & Forecasts to...